PROTECTION OF EXPERIMENTAL COBALT CARDIOMYOPATHY IN RATS BY SELENIUM SUPPLEMENT / 中国药理学通报

The protective effect of selenium ( Se ) on cobalt cardiomyopathy was investigated in rats given cobalt chloride ( 5 mg/kg?d-1?7 i.p.). Pretreatment of Se (50 ?g/kg?d-1 ?14 i.p.) could protect the myocardium injured by Co as demonstrated by the decrease in plasma CPK and GOT activities and absence of histopathologic abnormalities. Se contents in hearts and the cardiac glutathione peroxidase activity were increased, but the level of lipid peroxide in the heart was unaltered after i.p. Se. As compared with the Co group rats, SDH reaction was increased in intensity, lipid staining and free fatty acid contents in myocardium of the Se + Co group were decreased to the normal extent, indicating that the protective effect of Se appeared to be related to the prevention of the cobalt-induced inhibition of SDH and disturbance of lipid metabolism in the heart.

BIOAVAILABILITY OF SELENIUM IN SELENIUM-YEAST TO YOUNG RESIDENTS IN A KESHAN DISEASE AREA / 西安交通大学学报(医学版)

Abstract To evaluate the bioavailability of selenium (Se) in Se-yeast to residents with low-Se status, fifty-two youth in a Keshan disease area were randomly divided into three groups, and they were given orally 200 ?g Se daily as So-yeast or sodium selenite, or ordinary yeast for 12 weeks, respectively. Se contents and activities of glutathione peroxidase (GSHpx) in blood were measured at wk 4 and 8 of supplements and 8wk alter the supplements were discontinued. The results show that: 1. the retention of Se in either plasma or erythrocyte is sigificantly higher in Se-yeast than in sodiurn selenite; 2 the effect of Se in Se-yeast is superior to that of sodium selenite for maintaining GSHpx activities; and 3. the relative bioavailabilities of Se in Se-yeast are 556% and 178% when using erythrocyte and plasma Se contents as the response critria, as well as 158% and 116% when estimated by platelet and plasma GSHpx activities. The results indicate that the bioavailability of Se to the residents in a low-Se Keshan disease area is greater when supplemented Se-yeast than selenite.

PROTECTION OF ADRIAMYCIN-INDUCED SUBACUTE CARDIOMYOPATHY IN MOUSE BY SELENIUM PRETREATMENT / 西安交通大学学报(医学版)

The protective effect of selenium (So) on the subacute cardiomyopathy was investigated in the mouse given a single dose of adriamycin (ADR 17. 5mg/kg ip). Se pretreatment (80?g/kg?10 ip) produced protection against the ADR-induced early myocardial damage associated with increased permcability of cell membranes as evidenced by apparent D- PAS (diastase- periodic acid-Schiff) staining material noted in the sarcolemma. The protective effect of Se could be partially explained as the detoxication of lipid peroxides via the action of enhanced cardiac Se-glutathione peroxidase.

RELATIVE BIOAVAILABILITY OF SELENIUM IN Se-YEAST TO RATS FED ON LOW-Se DIET FROM A KESHAN DISEASE AREA / 西安交通大学学报(医学版)

In the present study the bioavailability of selenium in Se-yeast was compared with that in sodium selenite to rats fed on low-Se diet from a keshan discaes area. The bioavailability of selenium in Se-yeast when estimated by heart, liver kidney and erythrocyte Se contents was significantly greater than that in selenite at wk 2 and 4 of supplement, indicating that selenium in Se-yeast is more cfficiently retained in tissues than selenite selenium. When the criterion used was either platelet or liver glutathione peroxidase (GSH_(?)) activity, the bioavailability was lower for selenium in Se-yeast than for in selenite at wk 2, but higher at wk 4, showing that selenium from both selenite and Se-yeast is clearly available for GSH_(?), synthesis, "although Se-yeast restores GSH_(?) activity more slowly. In addition, the effect of selenium in Se-yeast in maintaining cither Se levels in heart and erythrocyte or GSH_(?) activities in platelets and liver was superior to that of selenite after the selenium supplements were withdrawn.

THE RELATIVE BIOAVAILABILITY OF SELENIUM IN ZIYANG HIGH-Se WHEAT TO SELENIUM-DEFICIENT RATS / 营养学报

A three-phase depletion/repletion/depletion feeding study was designed to investigate the changes of Se levels and glutathione peroxidase (GSH-Px) activities in tissues and blood in rats fed for 6 weeks low-Se diet (6 ppb Se) from a Keshan disease area during the supplementations of Se as Ziyang high-Se wheat (1.175 ppm Se) or sodium selenite (dietary Se 219 and 223 ppb respectively) and after the supplements were discontinued, and to evaluate the relative bioavailability of Se in the wheat. The resalts showed that the average bioavailability of Se in high-Se wheat derived from the values at wk 2, 4 and 6 of supplement was close to that in selenite when plasma, erythrocyte, kidney, liver and cardiac Se contents were used as the response criteria, the relative bioavailabilities being 98%, 104%,100%,96% and 101% (sodium selenite = 100%) respectively. The bioavailability was lower for Se in high-Se wheat (70% or 90%) than for selenite when estimated by erythro-cyte or cardiac GSH-Px activities. However, the bioavailabilities of high-Se wheat Se in various tissues were not all the same at different stages of supplement. In addition, the effect of Se in high-Se wheat in maintaining either Se levels in heart, liver and erythrocyte or GSH-Px activity in heart was superior to that of selenite 3 weeks after the Se supplements were withdrawn.